These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30706294)

  • 1. The nature of ligand efficiency.
    Kenny PW
    J Cheminform; 2019 Jan; 11(1):8. PubMed ID: 30706294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand efficiency metrics considered harmful.
    Kenny PW; Leitão A; Montanari CA
    J Comput Aided Mol Des; 2014 Jul; 28(7):699-710. PubMed ID: 24899110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How are fragments optimized? A retrospective analysis of 145 fragment optimizations.
    Ferenczy GG; Keserű GM
    J Med Chem; 2013 Mar; 56(6):2478-86. PubMed ID: 23437770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enthalpic efficiency of ligand binding.
    Ferenczy GG; Keseru GM
    J Chem Inf Model; 2010 Sep; 50(9):1536-41. PubMed ID: 20684566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations.
    Shultz MD
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5992-6000. PubMed ID: 24054120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pushing the Ligand Efficiency Metrics: Relative Group Contribution (RGC) Model as a Helpful Strategy to Promote a Fragment "Rescue" Effect.
    Vásquez AF; González Barrios A
    Front Chem; 2019; 7():564. PubMed ID: 31482085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand Efficiency Indices (LEIs): More than a Simple Efficiency Yardstick.
    Abad-Zapatero C; Blasi D
    Mol Inform; 2011 Mar; 30(2-3):122-32. PubMed ID: 27466763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand Efficiency.
    Reynolds CH; Reynolds RC
    J Chem Inf Model; 2017 Dec; 57(12):3086-3093. PubMed ID: 29111708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding efficiency: trends, physical basis, and implications.
    Reynolds CH; Tounge BA; Bembenek SD
    J Med Chem; 2008 Apr; 51(8):2432-8. PubMed ID: 18380424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand efficiency indices for effective drug discovery.
    Abad-Zapatero C
    Expert Opin Drug Discov; 2007 Apr; 2(4):469-88. PubMed ID: 23484756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.
    Murray CW; Carr MG; Callaghan O; Chessari G; Congreve M; Cowan S; Coyle JE; Downham R; Figueroa E; Frederickson M; Graham B; McMenamin R; O'Brien MA; Patel S; Phillips TR; Williams G; Woodhead AJ; Woolford AJ
    J Med Chem; 2010 Aug; 53(16):5942-55. PubMed ID: 20718493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmarking the Predictive Power of Ligand Efficiency Indices in QSAR.
    Cortes-Ciriano I
    J Chem Inf Model; 2016 Aug; 56(8):1576-87. PubMed ID: 27399907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.
    Williams G; Ferenczy GG; Ulander J; Keserű GM
    Drug Discov Today; 2017 Apr; 22(4):681-689. PubMed ID: 27916639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
    Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N
    J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Relationship between Nicotinic Acetylcholine Receptor Ligand Size, Efficiency, Efficacy, and C-Loop Opening.
    Ma Q; Tae HS; Wu G; Jiang T; Yu R
    J Chem Inf Model; 2017 Aug; 57(8):1947-1956. PubMed ID: 28718646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
    Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beware of ligand efficiency (LE): understanding LE data in modeling structure-activity and structure-economy relationships.
    Polanski J; Tkocz A; Kucia U
    J Cheminform; 2017 Sep; 9(1):49. PubMed ID: 29086197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.